NEJM Evidence & NEJM AI – trial access

Until 16.05.2025, Charles University has trial access to the NEJM Evidence and NEJM AI journals.   NEJM Evidence presents innovative, original research and fresh ideas in clinical trial design and decision-making. The journal provides a critical evaluation of research methods and results to support clinical decision-making. The original research that NEJM Evidence publishes falls along the … Read more

EMBASE – trial access (from 7/4)

From April 7th until May 6th, Charles University has trial access to the Embase database.   Embase is a bibliographic biomedical and pharmacological database that contains over 30 million articles from more than 8 thousand journals with daily updates. Thus, it allows its users to perform systematic reviews, check drug interactions, and monitor trends and … Read more